339
The European Commission starts public consultations on actions in the field of Rare Diseases. This announcement is published on the website of the Commission. Three main topics will be discussed. The most important social impact to us has the second one: Encouraging the EU Member States in developing national health policies. An expert from our Information Centre for Rare Diseases and Orphan Drugs attended the preliminary consultations regarding the European Action in the field of Rare Diseases and contributed as a member of the drafting group. In few weeks, the information about the public consultation will be available in Bulgarian.